These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29709270)

  • 41. The potencies and selectivities of four calcium antagonists as inhibitors of uterine contractions in the rat in vivo.
    Abel MH; Hollingsworth M
    Br J Pharmacol; 1985 May; 85(1):263-9. PubMed ID: 4027469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium channel antagonists in the treatment of asthma.
    Fish JE
    J Asthma; 1984; 21(6):407-18. PubMed ID: 6526775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Slow channel blockers.
    Covinsky JO; Hamburger SC
    South Med J; 1983 Jan; 76(1):55-64. PubMed ID: 6337401
    [No Abstract]   [Full Text] [Related]  

  • 44. The effects of calcium channel blockers, verapamil, nifedipine and diltiazem, on metabolic control in diabetic rats.
    Kaymaz AA; Tan H; Altuğ T; Büyükdevrim AS
    Diabetes Res Clin Pract; 1995 Jun; 28(3):201-5. PubMed ID: 8529499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of calcium blockers and Mn2+ on the response of isolated rat iris sphincter and dilator muscles to agonists and Ca2+.
    Narita S; Watanabe M
    J Pharmacobiodyn; 1982 Apr; 5(4):285-94. PubMed ID: 7120029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasodilator mechanism of KB-944, a new calcium antagonist.
    Morita T; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Ca2+ channel antagonists and benzodiazepine receptor ligands in normal and skinned rat urinary bladder.
    Martí-Cabrera M; Llopis P; Abengochea A; Ortiz JL; Climent VJ; Cortijo J; Morcillo EJ
    Eur J Pharmacol; 1994 Apr; 255(1-3):157-65. PubMed ID: 8026541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium ion blocking drugs.
    Resnekov L
    Compr Ther; 1982 Jul; 8(7):10-5. PubMed ID: 7116804
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of calcium channel blockers on neuromuscular blockade induced by aminoglycoside antibiotics.
    Del Pozo E; Baeyens JM
    Eur J Pharmacol; 1986 Aug; 128(1-2):49-54. PubMed ID: 3758187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gingival hyperplasia due to calcium antagonists.
    Prescrire Int; 1998 Apr; 7(34):54-5. PubMed ID: 10183386
    [No Abstract]   [Full Text] [Related]  

  • 51. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
    Grover GJ; Sleph PG
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM; Wang HX; Xia Q; Wong TM
    Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B; Ayala I; Castells MT; Doménech G; Sánchez-Polo MT; García-Partida P; Valdés M
    Biomed Pharmacother; 2005; 59(1-2):1-7. PubMed ID: 15740928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolonged inhibitory effects of nilvadipine (FR34235) following washout in isolated rabbit aorta and mesenteric artery.
    Furuta T
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):134-8. PubMed ID: 2452305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.
    Towart R
    J Cardiovasc Pharmacol; 1982; 4(6):895-902. PubMed ID: 6185780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcium-channel blocking agents for gastrointestinal disorders.
    Castell DO
    Am J Cardiol; 1985 Jan; 55(3):210B-213B. PubMed ID: 3881916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and ex vivo Ca-antagonistic effect of 2-methoxyethyl(E)-3-phenyl-2-propen-1-yl(+/-)-1,4-dihydro-2,6-dimethyl- 4-(3- nitrophenyl)pyridine-3,5-dicarboxylate (FRC-8653), a new dihydropyridine derivative.
    Hosono M; Iida H; Ikeda K; Hayashi Y; Dohmoto H; Hashiguchi Y; Yamamoto H; Watanabe N; Yoshimoto R
    J Pharmacobiodyn; 1992 Oct; 15(10):547-53. PubMed ID: 1494104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study on calcium channel antagonists in the human radial artery: clinical implications.
    He GW; Yang CQ
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):94-100. PubMed ID: 10612766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of calcium channel blockers on steroidogenesis stimulated by ACTH and cAMP in isolated rat adrenal cells.
    Matsuki M; Watanabe S; Ikeda M; Nishida S; Saito T
    Horm Metab Res; 1996 Aug; 28(8):374-6. PubMed ID: 8886822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of calcium channel blockers in the treatment of hypertension.
    Halperin AK; Cubeddu LX
    Am Heart J; 1986 Feb; 111(2):363-82. PubMed ID: 3511651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.